A massive document leak has laid bare how many cab drivers are scamming their customers, and how little is done about it.

MRNA's competitive landscape, particularly against Pfizer, and higher forward P/S ratio suggest the stock is overvalued and ...

Higher interest rates and improved capital buffers have strengthened European banks’ ability to pursue acquisitions. As rates ...

Look at some companies that have a monopolistic place in the marketplace and decide whether it's a good idea to invest in them. The list is populated with some big names.

The recent closure of HSBC’s Zing has sparked strong discussion about banks’ ability to compete in the challenging cross-border payments market. Some view it as proof that banks simply can’t keep up.